HD

Heather Davis

FT Forma Therapeutics: 8 patents #34 of 86Top 40%
Abbott: 3 patents #1,951 of 5,431Top 40%
EC Eisai R&D Management Co.: 3 patents #243 of 817Top 30%
AV Abb Vie: 1 patents #782 of 1,257Top 65%
VD Valo Early Discovery: 1 patents #27 of 30Top 90%
VH Valo Health: 1 patents #40 of 53Top 80%
Overall (All Time): #267,101 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2024-02-06
10988450 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2021-04-27
10464910 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-11-05
10464909 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-11-05
10457652 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-10-29
10442776 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-10-15
10421732 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-09-24
10214500 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-02-26
RE47193 Selectively substituted quinoline compounds J. Eric Carlson, Hans Hansen, Lynn Hawkins, Sally Ishizaka, Matthew Mackey +3 more 2019-01-08
9637453 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors Pui Yee Ng, Kenneth W. Bair, Aleksandra Rudnitskaya, Xiaozhang Zheng, Bingsong Han +2 more 2017-05-02
9630922 3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors Pui Yee Ng, Kenneth W. Bair, David S. Millan, Aleksandra Rudnitskaya, Xiaozhang Zheng +3 more 2017-04-25
9567339 Primary carboxamides as BTK inhibitors Dominique Bonafoux, Kristine E. Frank, Michael Friedman, J. Martin Herold, Michael Z. Hoemann +12 more 2017-02-14
9428495 Selectively substituted quinoline compounds Eric Carlson, Hans Hansen, Lynn Hawkins, Sally Ishizaka, Matthew Mackey +3 more 2016-08-30
8273736 Thienopyridine and furopyridine kinase inhibitors Patrick Betschmann, Andrew Burchat, David J. Calderwood, Michael L. Curtin, Steven K. Davidsen +9 more 2012-09-25
7737160 Thienopyridine and furopyridine kinase inhibitors Patrick Betschmann, Andrew Burchat, David J. Calderwood, Michael L. Curtin, Steven K. Davidsen +9 more 2010-06-15
7666875 Hydantoin compounds Brian Gallagher, Eric Carlson, Qian Chen, Shawn Schiller, Christina Shaffer +2 more 2010-02-23
7202363 Thienopyridine and furopyridine kinase inhibitors Patrick Betschmann, Andrew Burchat, David J. Calderwood, Michael L. Curtin, Steven K. Davidsen +9 more 2007-04-10